The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflamm

1.Kerrigan RW. Agaricus subrufescens, a cultivated edible and medicinal mushroom, and its synonyms.Mycologia .2005; 97 (1):12–24. [PubMed]

2.Huang N. Brazilian mushroom (Gee Song Rong) In: Huang N, editor. Cultivation of Eigth Rare and Precious Gourmet Mushrooms .Chinese Agriculture University Press; 1997. pp. 95–101.

3.Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective.Critical Reviews in Immunology .1999; 19 (1):65–96. [PubMed]

4.Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, Yadomae T. Antitumorβ -glucan from the cultured fruit body ofAgaricus blazei .Biological and Pharmaceutical Bulletin .2001; 24 (7):820–828. [PubMed]

5.Itoh H, Ito H, Amano H, Noda H. Inhibitory action of a (1→6)- β -D-glucan-protein complex (F III-2-b) isolated fromAgaricus blazeiMurill (’Himematsutake’) on Meth A fibrosarcoma-bearing mice and its antitumor mechanism.Japanese Journal of Pharmacology .1994; 66 (2):265–271. [PubMed]

6.Czop JK, Valiante NM, Janusz MJ. Phagocytosis of particulate activators of the human alternative complement pathway through monocyte beta-glucan receptors.Progress in Clinical and Biological Research .1989; 297 :287–296. [PubMed]

7.Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC. Toll-like receptors as key mediators in innate antifungal immunity.Medical Mycology .2004; 42 (6):485–498. [PubMed]

8.Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2.Journal of Experimental Medicine .2003; 197 (9):1107–1117. [PMC free article] [PubMed]

9.Goodridge HS, Wolf AJ, Underhill DM.β -glucan recognition by the innate immune system.Immunological Reviews .2009; 230 (1):38–50. [PubMed]

10.Endo M, Beppu H, Akiyama H, et al. Agaritine purified fromAgaricus blazeiMurrill exerts anti-tumor activity against leukemic cells.Biochimica et Biophysica Acta .2010; 1800 (7):669–673. [PubMed]

11.Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound fromAgaricus blazeiMurill and its mechanism of action.Journal of Nutrition .2001; 131 (5):1409–1413. [PubMed]

12.Oh TW, Kim YA, Jang WJ, et al. Semipurified fractions from the submerged-culture broth ofAgaricus blazeiMurill reduce blood glucose levels in streptozotocin-induced diabetic rats.Journal of Agricultural and Food Chemistry .2010; 58 (7):4113–4119. [PubMed]

13.Hetland G, Johnson E, Lyberg T, Bernardshaw S, Tryggestad AMA, Grinde B. Effects of the medicinal mushroomAgaricus blazeiMurill on immunity, infection and cancer.Scandinavian Journal of Immunology .2008; 68 (4):363–370. [PubMed]

14.Bernardshaw S, Johnson E, Hetland G. An extract of the mushroomAgaricus blazeiMurill administered orally protects against systemicStreptococcus pneumoniaeinfection in mice.Scandinavian Journal of Immunology .2005; 62 (4):393–398. [PubMed]

15.Bernardshaw S, Hetland G, Grinde B, Johnson E. An extract of the mushroomAgaricus blazeiMurill protects against lethal septicemia in a mouse model of fecal peritonitis.Shock .2006; 25 (4):420–425. [PubMed]

16.Ellertsen LK, Hetland G. An extract of the medicinal mushroomAgaricus blazeiMurill can protect against allergy.Clinical and Molecular Allergy .2009; 7, article no. 6[PMC free article] [PubMed]

17.Romagnani S. The Th1/Th2 paradigm.Immunology Today .1997; 18 :263–266. [PubMed]

18.Takimoto H, Kato H, Kaneko M, Kumazawa Y. Amelioration of skewed Th1/Th2 balance in tumor-bearing and asthma-induced mice by oral administration ofAgaricus blazeiextracts.Immunopharmacology and Immunotoxicology .2008; 30 (4):747–760. [PubMed]

19.Pelligrini P, Berghella AM, Del Beato T, et al. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progession.Cancer Research .1998; 42 :1–8. [PubMed]

20.Lienhardt C, Azzurri A, Amedei A, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo.European Journal of Immunology .2002; 32 (6):1605–1613. [PubMed]

21.Ellertsen LK, Wiker HG, Egeberg NT, Hetland G. Allergic sensitisation in tuberculosis and leprosy patients.International Archives of Allergy and Immunology .2005; 138 (3):217–224. [PubMed]

22.Hetland G, Løvik M, Wiker HG. Protective effect ofβ -glucan against Mycobacterium bovis, BCG infection in BALB/c mice.Scandinavian Journal of Immunology .1998; 47 (6):548–553. [PubMed]

23.Johnson E, Førland DT, Sætre L, Bernardshaw SV, Lyberg T, Hetland G. Effect of an extract based on the medicinal mushroomAgaricus blazeiMurill on release of cytokines, chemokines and leukocyte growth factors in human bloodex vivoand in vivo.Scandinavian Journal of Immunology .2009; 69 (3):242–250. [PubMed]

24.Førland DT, Johnson E, Sætre L, Lyberg T, Lygren I, Hetland G. Effect of an extract based on the medicinal mushroomAgaricus blazeiMurill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn’s disease.Scandinavian Journal of Immunology .2011; 73 (1):66–75. [PubMed]

25.Lee IP, Kang BH, Roh JK, Kim JR. Lack of carcinogenicity of lyophilizedAgaricus blazeiMurill in a F344 rat two year bioassay.Food and Chemical Toxicology .2008; 46 (1):87–95. [PubMed]

26.Kumagai Y, Akira S. Identification and functions of pattern-recognition receptors.Journal of Allergy and Clinical Immunology .2010; 125 (5):985–992. [PubMed]

27.Tryggestad AMA, Espevik T, Førland DT, et al. The medical mushroomAgaricus blazeiMurill activates NF- κ B via TLR2. In: Proceedings of the 13th International Congress of Immunology; August 2007; Rio de Janeiro, Brazil. p. 1193.P2.23 INI-02 Signalling pathways of innate immune receptors .

28.Bernardshaw S, Lyberg T, Hetland G, Johnson E. Effect of an extract of the mushroomAgaricus blazeiMurill on expression of adhesion molecules and production of reactive oxygen species in monocytes and granulocytes in human whole bloodex vivo .Acta Pathologica, Microbiologica, et Immunologica Scandinavica .2007; 115 (6):719–725. [PubMed]

29.Bernardshaw S, Hetland G, Ellertsen LK, Tryggestad AMA, Johnson E. An extract of the medicinal mushroomAgaricus blazeiMurill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro.Inflammation .2005; 29 (4–6):147–153. [PubMed]

30.Fitzner N, Clauberg S, Essmann F, Liebmann J, Kolb-Bachofen V. Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands.Clinical and Vaccine Immunology .2008; 15

(1):138–146. [PMC free article] [PubMed]

31.Ahn WS, Kim DJ, Chae GT, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract,Agaricus blazeiMurill Kyowa, in gynecological cancer patients undergoing chemotherapy.International Journal of Gynecological Cancer .2004; 14 (4):589–594. [PubMed]

32.Geddes K, Magalhães JG, Girardin SE. Unleashing the therapeutic potential of NOD-like receptors.Nature Reviews Drug Discovery .2009; 8 (6):465–479. [PubMed]

33.Benko S, Magyarics Z, Szabó A, Rajnavölgyi E. Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors.Biological Chemistry .2008; 389 (5):469–485. [PubMed]

34.Suzuki T, Ohno N, Saito K, Yadomae T. Activation of the complement system by (1→3)- β -D-glucans having different degrees of branching and different ultrastructures.Journal of Pharmacobio-Dynamics .1992; 15 (6):277–285. [PubMed]

35.Chan GC, Chan WK, Sze DM. The effects of beta-glucan on human immune and cancer cells.Journal of Hematology & Oncology .2009; 2 :p. 25. [PMC free article] [PubMed]

36.Sorimachi K, Akimoto K, Ikehara Y, Inafuku K, Okubo A, Yamazaki S. Secretion of TNF- α , IL-8 and nitric oxide by macrophages activated withAgaricus blazeiMurill fractions in vitro.Cell Structure and Function .2001; 26 (2):103–108. [PubMed]

37.Volman JJ, Helsper JPFG, Wei S, et al. Effects of mushroom-derivedβ -glucan-rich polysaccharide extracts on nitric oxide production by bone marrow-derived macrophages and nuclear factor- κ b transactivation in Caco-2 reporter cells: can effects be explained by structure?Molecular Nutrition and Food Research .2010; 54 (2):268–276. [PubMed]

38.Niu YC, Liu JC, Zhao XM, Wu XX. A low molecular weight polysaccharide isolated fromAgaricus blazeisuppresses tumor growth and angiogenesis in vivo.Oncology Reports .2009; 21 (1):145–152. [PubMed]

39.Kimura Y, Kido T, Takaku T, Sumiyoshi M, Baba K. Isolation of an anti-angiogenic substance fromAgaricus blazeiMurill: its antitumor and antimetastatic actions.Cancer Science .2004; 95 (9):758–764. [PubMed]

40.Fujimiya Y, Suzuki Y, Oshiman KI, et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete,Agaricus blazeiMurill, mediated via natural killer cell activation and apoptosis.Cancer Immunology Immunotherapy .1998; 46 (3):147–159. [PubMed]

41.Kobayashi H, Yoshida R, Kanada Y, et al. Suppressing effects of daily oral supplementation of beta-glucan extracted fromAgaricus blazeiMurill on spontaneous and peritoneal disseminated metastasis in mouse model.Journal of Cancer Research and Clinical Oncology .2005; 131 (8):527–538. [PubMed]

42.Xiaohui T, Lun Z, Wang J, et al. Clinical observation on treatment of acute nonlymphocytic leukemia withAgaricus blazeiMurill.Journal of Lanzhou Medical College .1994; 20 :169–171.

43.Murakawa K, Fukunaga K, Tanouchi M, Hosokawa M, Hossain Z, Takahashi K. Therapy of myeloma in vivo using marine phospholipid in combination withAgaricus blazeiMurill as an immune respond activator.Journal of Oleo Science .2007; 56 (4):179–188. [PubMed]

44.Yu CH, Kan SF, Shu CH, Lu TJ, Sun-Hwang L, Wang PS. Inhibitory mechanisms ofAgaricus blazeiMurill on the growth of prostate cancer in vitro and in vivo.Journal of Nutritional Biochemistry .2009; 20 (10):753–764. [PubMed]

45.Balkwill F, Mantovani A. Cancer and inflammation: implications for pharmacology and therapeutics.Clinical Pharmacology and Therapeutics .2010; 87 (4):401–406. [PubMed]

46.Grinde B, Hetland G, Johnson E. Effects on gene expression and viral load of a medicinal extract fromAgaricus blazeiin patients with chronic hepatitis C infection.International Immunopharmacology .2006; 6 (8):1311–1314. [PubMed]

47.Hsu CH, Hwang KC, Chiang YH, Chou P. The mushroomAgaricus blazeiMurill extract normalizes liver function in patients with chronic hepatitis B.Journal of Alternative and Complementary Medicine .2008; 14 (3):299–301. [PubMed]

48.Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P. The mushroomAgaricus blazeiMurill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial.Journal of Alternative and Complementary Medicine .2007; 13 (1):97–102. [PubMed]

49.Zittermann A. Effects of vitamin K on calcium and bone metabolism.Current Opinion in Clinical Nutrition and Metabolic Care .2001; 4 (6):483–487. [PubMed]

50.Førland DT, Johnson E, Tryggestad AMA, Lyberg T, Hetland G. An extract based on the medicinal mushroomAgaricus blazeiMurill stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro.Cytokine .2010; 49 (3):245–250. [PubMed]

51.Chen L, Shao HJ, Su YB. Coimmunization ofAgaricus blazeiMurill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses.International Immunopharmacology .2004; 4 (3):403–409. [PubMed]

52.Chen L, Shao H. Extract fromAgaricus blazeiMurill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease.Veterinary Immunology and Immunopathology .2006; 109 (1-2):177–182. [PubMed]

53.Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.Clinical and Experimental Immunology .2007; 148 (1):32–46. [PMC free article] [PubMed]

54.Yazawa Y, Yokota M, Sugiyama K. Antitumor promoting effect of an active component of polyporus, ergosterol and related compounds on rat urinary bladder carcinogenesis in a short-term test with concanavalin A.Biological and Pharmaceutical Bulletin .2000; 23 (11):1298–1302. [PubMed]

55.Viola A. Improving cancer immunotherapy by preventing chemokine nitration.European Journal of Cancer Supplment .2010; 8 :p. 89.

56.Schetter AJ, Heegaard NHH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.Carcinogenesis .2009; 31 (1):37–49.Article ID bgp272.[PMC free article] [PubMed]

57.Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials.International Journal of Cancer .2007; 121 (11):2373–2380. [PubMed]

58.Yoshimura K, Kamoto T, Ogawa O, et al. Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: an open-label study.International Journal of Urology .2010; 17 (6):548–554. [PubMed]

59.Jiang J, Sliva D. Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells.International Journal of Oncology .2010; 37 (6):1529–1536. [PubMed]

Category: Cancer-2

Similar articles: